// Dermatology - Drugs
// Auto-generated from modularize-data.js

const drugs = [

    {
        "id": "tretinoin",
        "name": "Tretinoin",
        "pharmacologicClass": "topical-retinoids",
        "therapeuticClass": "acne-medications",
        "system": "dermatology",
        "mechanism": "Normalize follicular keratinization, reduce comedone formation.",
        "features": "First-generation retinoid, most studied.",
        "clinicalChoice": "Comedonal acne, photoaging.",
        "indications": [
            "Acne Vulgaris",
            "Photoaging"
        ],
        "contraindications": [
            "Pregnancy",
            "Eczema"
        ],
        "sideEffects": [
            "Skin irritation",
            "Photosensitivity",
            "Teratogenic"
        ],
        "interactions": "Other topical irritants increase skin irritation.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "adapalene",
        "name": "Adapalene",
        "pharmacologicClass": "topical-retinoids",
        "therapeuticClass": "acne-medications",
        "system": "dermatology",
        "mechanism": "Normalize follicular keratinization, reduce comedone formation.",
        "features": "Third-generation, less irritating.",
        "clinicalChoice": "Sensitive skin acne.",
        "indications": [
            "Acne Vulgaris"
        ],
        "contraindications": [
            "Pregnancy"
        ],
        "sideEffects": [
            "Skin irritation",
            "Photosensitivity",
            "Teratogenic"
        ],
        "interactions": "Other topical irritants increase skin irritation.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "isotretinoin",
        "name": "Isotretinoin",
        "pharmacologicClass": "isotretinoin",
        "therapeuticClass": "acne-medications",
        "system": "dermatology",
        "mechanism": "Reduces sebum production, normalizes keratinization, anti-inflammatory.",
        "features": "Requires iPLEDGE program, pregnancy prevention.",
        "clinicalChoice": "Severe cystic acne, acne resistant to other treatments.",
        "indications": [
            "Severe Acne"
        ],
        "contraindications": [
            "Pregnancy",
            "Breastfeeding"
        ],
        "sideEffects": [
            "Severe teratogenicity",
            "Depression",
            "Dry skin/lips",
            "Hepatotoxicity"
        ],
        "interactions": "Vitamin A supplements (hypervitaminosis A), tetracyclines (pseudotumor cerebri).",
        "interactionDetails": "TETRACYCLINES: MECHANISM - Both isotretinoin and tetracyclines can increase intracranial pressure. CONSEQUENCE - Risk of pseudotumor cerebri with severe headaches and vision changes.",
        "pageType": "drug"
    },
    {
        "id": "clotrimazole",
        "name": "Clotrimazole",
        "pharmacologicClass": "azole-antifungals",
        "therapeuticClass": "topical-antifungals",
        "system": "dermatology",
        "mechanism": "Inhibit ergosterol synthesis by blocking 14α-demethylase.",
        "features": "Broad-spectrum imidazole.",
        "clinicalChoice": "Candidiasis, dermatophytes.",
        "indications": [
            "Tinea Infections",
            "Candidiasis"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "sideEffects": [
            "Local irritation",
            "Contact dermatitis"
        ],
        "interactions": "Minimal systemic absorption, few interactions.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "ketoconazole",
        "name": "Ketoconazole",
        "pharmacologicClass": "azole-antifungals",
        "therapeuticClass": "topical-antifungals",
        "system": "dermatology",
        "mechanism": "Inhibit ergosterol synthesis by blocking 14α-demethylase.",
        "features": "Available as cream and shampoo.",
        "clinicalChoice": "Seborrheic dermatitis, tinea versicolor.",
        "indications": [
            "Seborrheic Dermatitis",
            "Tinea Versicolor"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "sideEffects": [
            "Local irritation",
            "Contact dermatitis"
        ],
        "interactions": "Minimal systemic absorption, few interactions.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "terbinafine",
        "name": "Terbinafine",
        "pharmacologicClass": "allylamine-antifungals",
        "therapeuticClass": "topical-antifungals",
        "system": "dermatology",
        "mechanism": "Inhibit squalene epoxidase, fungicidal.",
        "features": "Fungicidal, shorter treatment duration.",
        "clinicalChoice": "Dermatophyte infections, onychomycosis.",
        "indications": [
            "Tinea Infections",
            "Onychomycosis"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "sideEffects": [
            "Local burning",
            "Skin irritation"
        ],
        "interactions": "None significant.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "hydrocortisone",
        "name": "Hydrocortisone",
        "pharmacologicClass": "glucocorticoids",
        "therapeuticClass": "topical-corticosteroids",
        "system": "dermatology",
        "mechanism": "Anti-inflammatory, immunosuppressive, vasoconstrictive effects.",
        "features": "Low potency, safe for face and children. | Physiologic replacement dose.",
        "clinicalChoice": "Mild eczema, contact dermatitis.",
        "indications": [
            "Adrenal Insufficiency",
            "Contact Dermatitis",
            "Eczema",
            "Inflammatory Skin Conditions"
        ],
        "contraindications": [
            "Viral Skin Infections"
        ],
        "sideEffects": [
            "Skin atrophy",
            "Striae",
            "Systemic absorption",
            "Rebound dermatitis"
        ],
        "interactions": "Occlusive dressings increase absorption.",
        "interactionDetails": "",
        "pageType": "drug",
        "pharmacologicClasses": [
            "glucocorticoids",
            "low-to-high-potency-steroids"
        ]
    },
    {
        "id": "triamcinolone",
        "name": "Triamcinolone",
        "pharmacologicClass": "low-to-high-potency-steroids",
        "therapeuticClass": "topical-corticosteroids",
        "system": "dermatology",
        "mechanism": "Anti-inflammatory, immunosuppressive, vasoconstrictive effects.",
        "features": "Medium potency, versatile.",
        "clinicalChoice": "Moderate inflammatory skin conditions.",
        "indications": [
            "Psoriasis",
            "Eczema"
        ],
        "contraindications": [
            "Skin Infections"
        ],
        "sideEffects": [
            "Skin atrophy",
            "Striae",
            "Systemic absorption",
            "Rebound dermatitis"
        ],
        "interactions": "Occlusive dressings increase absorption.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "clobetasol",
        "name": "Clobetasol",
        "pharmacologicClass": "low-to-high-potency-steroids",
        "therapeuticClass": "topical-corticosteroids",
        "system": "dermatology",
        "mechanism": "Anti-inflammatory, immunosuppressive, vasoconstrictive effects.",
        "features": "Very high potency, limited use.",
        "clinicalChoice": "Severe psoriasis, lichen planus.",
        "indications": [
            "Severe Psoriasis",
            "Lichen Planus"
        ],
        "contraindications": [
            "Facial Use",
            "Children"
        ],
        "sideEffects": [
            "Skin atrophy",
            "Striae",
            "Systemic absorption",
            "Rebound dermatitis"
        ],
        "interactions": "Occlusive dressings increase absorption.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "tacrolimus-topical",
        "name": "Tacrolimus (Topical)",
        "pharmacologicClass": "topical-calcineurin-inhibitors",
        "therapeuticClass": "topical-immunomodulators",
        "system": "dermatology",
        "mechanism": "Inhibit calcineurin to block T-cell activation and cytokine release.",
        "features": "Steroid-sparing agent for sensitive areas (face, neck).",
        "clinicalChoice": "Atopic dermatitis, especially on face and intertriginous areas.",
        "indications": [
            "Atopic Dermatitis"
        ],
        "contraindications": [
            "Skin Infections",
            "Immunocompromised Patients"
        ],
        "sideEffects": [
            "Burning sensation",
            "Skin infections",
            "Potential lymphoma risk (black box warning)"
        ],
        "interactions": "CYP3A4 inhibitors may increase systemic absorption.",
        "interactionDetails": "LYMPHOMA RISK: MECHANISM - Unclear, possibly related to local immunosuppression. CONSEQUENCE - Black box warning for potential malignancy risk, use as second-line therapy.",
        "pageType": "drug"
    },
    {
        "id": "pimecrolimus",
        "name": "Pimecrolimus",
        "pharmacologicClass": "topical-calcineurin-inhibitors",
        "therapeuticClass": "topical-immunomodulators",
        "system": "dermatology",
        "mechanism": "Inhibit calcineurin to block T-cell activation and cytokine release.",
        "features": "Lower potency than tacrolimus, for mild-moderate disease.",
        "clinicalChoice": "Mild to moderate atopic dermatitis.",
        "indications": [
            "Mild to Moderate Atopic Dermatitis"
        ],
        "contraindications": [
            "Skin Infections",
            "Immunocompromised Patients"
        ],
        "sideEffects": [
            "Burning sensation",
            "Skin infections",
            "Potential lymphoma risk (black box warning)"
        ],
        "interactions": "CYP3A4 inhibitors may increase systemic absorption.",
        "interactionDetails": "LYMPHOMA RISK: MECHANISM - Unclear, possibly related to local immunosuppression. CONSEQUENCE - Black box warning for potential malignancy risk, use as second-line therapy.",
        "pageType": "drug"
    },
    {
        "id": "mupirocin",
        "name": "Mupirocin",
        "pharmacologicClass": "topical-antibiotics",
        "therapeuticClass": "topical-antibacterials",
        "system": "dermatology",
        "mechanism": "Inhibit bacterial isoleucyl-tRNA synthetase, preventing protein synthesis.",
        "features": "Effective against MRSA, used for nasal decolonization.",
        "clinicalChoice": "Impetigo, MRSA decolonization.",
        "indications": [
            "Impetigo",
            "MRSA Decolonization"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "sideEffects": [
            "Local irritation",
            "Burning sensation"
        ],
        "interactions": "None significant.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "clindamycin-topical",
        "name": "Clindamycin (Topical)",
        "pharmacologicClass": "topical-antibiotics",
        "therapeuticClass": "topical-antibacterials",
        "system": "dermatology",
        "mechanism": "Inhibit 50S ribosomal subunit, preventing bacterial protein synthesis.",
        "features": "Topical antibiotic for acne, often combined with benzoyl peroxide.",
        "clinicalChoice": "Moderate acne vulgaris.",
        "indications": [
            "Acne Vulgaris"
        ],
        "contraindications": [
            "History of Pseudomembranous Colitis"
        ],
        "sideEffects": [
            "Skin dryness",
            "Peeling",
            "Burning sensation"
        ],
        "interactions": "Benzoyl peroxide inactivates topical erythromycin but not clindamycin.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "ustekinumab",
        "name": "Ustekinumab",
        "pharmacologicClass": "il-12-23-inhibitors",
        "therapeuticClass": "psoriasis-biologics",
        "system": "dermatology",
        "mechanism": "Monoclonal antibody against IL-12 and IL-23, reducing T-cell activation.",
        "features": "IL-12/23 inhibitor, less frequent dosing (every 12 weeks).",
        "clinicalChoice": "Moderate to severe psoriasis, psoriatic arthritis.",
        "indications": [
            "Moderate to Severe Psoriasis",
            "Psoriatic Arthritis",
            "Crohn Disease"
        ],
        "contraindications": [
            "Active Infection",
            "Latent TB"
        ],
        "sideEffects": [
            "Infection risk",
            "Injection site reactions",
            "Antibody formation"
        ],
        "interactions": "Live vaccines contraindicated.",
        "interactionDetails": "LIVE VACCINES: MECHANISM - IL-12/23 blockade impairs immune response. CONSEQUENCE - Risk of disseminated infection from live vaccines. Complete vaccinations before starting therapy.",
        "pageType": "drug"
    }

];export default drugs;
